(1 - 5 von 13
)
Patent losses hit AstraZeneca harder than rivals - elEconomista.es
www.eleconomista.es
"In Europe, AstraZeneca will be the only company with declining sales in the coming years," said Britta Holt of Fitch Ratings. "Novartis is in an ...
Fitch cuts Roche rating on Genentech deal | Reuters
www.reuters.com
Fitch Ratings on Friday cut its credit rating and outlook on Roche Holding citing the company's increased debt after a deal was reached for it to buy the
Aktuelle Ratings für die Pharmabranche | CHEManager
www.chemanager-online.com
... Aktienrückkaufprogramm auf insgesamt 5 Mrd. US-$ (s. auch Tabelle 2). Britta Holt Fitch Ratings · Facebook Twitter LinkedIn Xing WhatsApp ...
Merckle family may sell Phoenix, Heidelberg stakes - The ...
economictimes.indiatimes.com
— Phoenix is certainly an attractive wholesale business to acquire, said Britta Holt, a director at Fitch Ratings in London. › news
sortiert nach Relevanz / Datum